Theravance Biopharma
TBPH
#6853
Rank
NZ$0.65 B
Marketcap
Cayman Islands
Country
$13.40
Share price
0.24%
Change (1 day)
-10.36%
Change (1 year)

Market capitalization of Theravance Biopharma (TBPH)

Market cap: NZ$0.65 Billion

As of September 2024 Theravance Biopharma has a market cap of NZ$0.65 Billion. This makes Theravance Biopharma the world's 6853th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Theravance Biopharma from 2014 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$0.65 B-25.93%
2023NZ$0.88 B-25.65%
2022NZ$1.19 B0.11%
2021NZ$1.18 B-25.18%
2020NZ$1.58 B-27.37%
2019NZ$2.18 B3.06%
2018NZ$2.12 B-0.07%
2017NZ$2.12 B-11.12%
2016NZ$2.39 B162.54%
2015NZ$0.91 B48.59%
2014NZ$0.61 B

End of Day market cap according to different sources

On Sep 18th, 2024 the market cap of Theravance Biopharma was reported to be:

NZ$0.65 Billion
by Yahoo Finance info icon info icon
NZ$0.65 Billion
by CompaniesMarketCap info icon info icon
NZ$0.65 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$2.02 B 208.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.09 B 981.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.03 B 514.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.67 B 2,595.58%๐Ÿ‡บ๐Ÿ‡ธ USA